Intact working memory in non-manifesting LRRK2 carriers - an fMRI study

European Journal of Neuroscience

Volumn 43, Issue 1, 2016, Pages 106-112

  Thaler, Avner ^a,b   Helmich, Rick C ^c   Or Borichev, Ayelet ^a   van Nuenen, Bart F L ^d   Shapira Lichter, Irit ^a   Gurevich, Tanya ^a,b   Orr Urtreger, Avi ^a,b   Marder, Karen ^e   Bressman, Susan ^f   Bloem, Bastiaan R ^c   Giladi, Nir ^a,b   Hendler, Talma ^a,b   Mirelman, Anat ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RADBOUD UNIVERSITY   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e NewYork Presbyterian Hospital   (United States)

^f BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

fMRI; G2019S; LRRK2; N back; Working memory

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ARTICLE; BECK DEPRESSION INVENTORY; CINGULATE GYRUS; DORSOLATERAL PREFRONTAL CORTEX; EXECUTIVE FUNCTION; EXON; EXPLORATORY RESEARCH; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENE MUTATION; HUMAN; IMAGE ANALYSIS; INTRAPARIETAL SULCUS; LRRK2 GENE; MONTREAL COGNITIVE ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ODOR RECOGNITION TEST; PARIETAL LOBE; PARKINSON DISEASE; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; REACTION TIME; RELATIVE; STROOP TEST; TASK PERFORMANCE; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL STIMULATION; WORKING MEMORY; ADULT; BRAIN; BRAIN MAPPING; FAMILY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HETEROZYGOTE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SHORT TERM MEMORY;

ADULT; BRAIN; BRAIN MAPPING; EXECUTIVE FUNCTION; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; LEUCINE-RICH REPEAT SERINE-THREONINE PROTEIN KINASE-2; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; STROOP TEST;

EID: 84955354558     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.13120     Document Type: Article

References (38)

1. Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., Burn, D., Barone, P., Pagonabarraga, J., Allcock, L., Santangelo, G., Foltynie, T., Janvin, C., Larsen, J.P., Barker, R.A. & Emre, M. (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology, 75, 1062-1069.
2. Alcalay, R.N., Mirelman, A., Saunders-Pullman, R., Tang, M.X., Mejia Santana, H., Raymond, D., Roos, E., Orbe-Reilly, M., Gurevich, T., Bar Shira, A., Gana Weisz, M., Yasinovsky, K., Zalis, M., Thaler, A., Deik, A., Barrett, M.J., Cabassa, J., Groves, M., Hunt, A.L., Lubarr, N., San Luciano, M., Miravite, J., Palmese, C., Sachdev, R., Sarva, H., Severt, L., Shanker, V., Swan, M.C., Soto-Valencia, J., Johannes, B., Ortega, R., Fahn, S., Cote, L., Waters, C., Mazzoni, P., Ford, B., Louis, E., Levy, O., Rosado, L., Ruiz, D., Dorovski, T., Pauciulo, M., Nichols, W., Orr-Urtreger, A., Ozelius, L., Clark, L., Giladi, N., Bressman, S. & Marder, K.S. (2013) Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations. Mov. Disord., 28, 1966-1971.
3. Bleich-Cohen, M., Hendler, T., Weizman, R., Faragian, S., Weizman, A. & Poyurovsky, M. (2014) Working memory dysfunction in schizophrenia patients with obsessive-compulsive symptoms: an fMRI study. Eur. Psychiat., 29, 160-166.
4. Bradley, V.A., Welch, J.L. & Dick, D.J. (1989) Visuospatial working memory in Parkinson's disease. J. Neurol. Neurosur. PS, 52, 1228-1235.
5. Bruck, A., Aalto, S., Rauhala, E., Bergman, J., Marttila, R. & Rinne, J.O. (2009) A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen. Mov. Disord., 24, 1009-1015.
6. Callicott, J.H., Mattay, V.S., Bertolino, A., Finn, K., Coppola, R., Frank, J.A., Goldberg, T.E. & Weinberger, D.R. (1999) Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb. Cortex, 9, 20-26.
7. Cools, R., Gibbs, S.E., Miyakawa, A., Jagust, W. & D'Esposito, M. (2008) Working memory capacity predicts dopamine synthesis capacity in the human striatum. J. Neurosci., 28, 1208-1212.
8. Fahn, S. (1987) Unified Parkinson's Disease Rating Scale. Macmillan Health Care Information, Florham Park, NJ.
9. Gan-Or, Z., Giladi, N., Rozovski, U., Shifrin, C., Rosner, S., Gurevich, T., Bar-Shira, A. & Orr-Urtreger, A. (2008) Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology, 70, 2277-2283.
10. Helmich, R.C., Thaler, A., van Nuenen, B.F., Gurevich, T., Mirelman, A., Marder, K.S., Bressman, S., Orr-Urtreger, A., Giladi, N., Bloem, B.R. & Toni, I. (2015) Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers. Neurology, 84, 399-406.
11. Jaeggi, S.M., Buschkuehl, M., Perrig, W.J. & Meier, B. (2010) The concurrent validity of the N-back task as a working memory measure. Memory, 18, 394-412.
12. Kehagia, A.A., Barker, R.A. & Robbins, T.W. (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol, 9, 1200-1213.
13. Landau, S.M., Lal, R., O'Neil, J.P., Baker, S. & Jagust, W.J. (2009) Striatal dopamine and working memory. Cereb. Cortex, 19, 445-454.
14. Litvan, I., Goldman, J.G., Troster, A.I., Schmand, B.A., Weintraub, D., Petersen, R.C., Mollenhauer, B., Adler, C.H., Marder, K., Williams-Gray, C.H., Aarsland, D., Kulisevsky, J., Rodriguez-Oroz, M.C., Burn, D.J., Barker, R.A. & Emre, M. (2011) Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov. Disord., 27, 349-356.
15. Marklund, P., Larsson, A., Elgh, E., Linder, J., Riklund, K.A., Forsgren, L. & Nyberg, L. (2009) Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory. Brain, 132, 336-346.
16. McNab, F. & Klingberg, T. (2008) Prefrontal cortex and basal ganglia control access to working memory. Nat. Neurosci., 11, 103-107.
17. McNab, F., Varrone, A., Farde, L., Jucaite, A., Bystritsky, P., Forssberg, H. & Klingberg, T. (2009) Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science, 323, 800-802.
18. Mirelman, A., Gurevich, T., Giladi, N., Bar-Shira, A., Orr-Urtreger, A. & Hausdorff, J.M. (2011) Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann. Neurol., 69, 193-197.
19. Mirelman, A., Heman, T., Yasinovsky, K., Thaler, A., Gurevich, T., Marder, K., Bressman, S., Bar-Shira, A., Orr-Urtreger, A., Giladi, N. & Hausdorff, J.M. (2013) Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation. Mov Disord., 28, 1683-1690.
20. Mirelman, A., Alcalay, R.N., Saunders-Pullman, R., Yasinovsky, K., Thaler, A., Gurevich, T., Mejia-Santana, H., Raymond, D., Gana-Weisz, M., Bar-Shira, A., Ozelius, L., Clark, L., Orr-Urtreger, A., Bressman, S., Marder, K. & Giladi, N. (2015) Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Mov. Disord., 30, 981-986.
21. Muslimovic, D., Post, B., Speelman, J.D. & Schmand, B. (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65, 1239-1245.
22. Nasreddine, Z.S., Phillips, N. & Chertkow, H. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc., 53, 695-699.
23. van Nuenen, B.F., Helmich, R.C., Ferraye, M., Thaler, A., Hendler, T., Orr-Urtreger, A., Mirelman, A., Bressman, S., Marder, K.S., Giladi, N., van de Warrenburg, B.P., Bloem, B.R., Toni, I. & LRRK2 Ashkenazi Jewish. (2012) Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism. Brain, 135, 3687-3698.
24. Orr-Urtreger, A., Shifrin, C., Rozovski, U., Rosner, S., Bercovich, D., Gurevich, T., Yagev-More, H., Bar-Shira, A. & Giladi, N. (2007) The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology, 69, 1595-1602.
25. Owen, A.M., McMillan, K.M., Laird, A.R. & Bullmore, E. (2005) N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum. Brain Mapp., 25, 46-59.
26. Ozelius, L.J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A.L., Klein, C., Henick, B., Hailpern, S.M., Lipton, R.B., Soto-Valencia, J., Risch, N. & Bressman, S.B. (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med., 354, 424-425.
27. Ranchet, M., Paire-Ficout, L., Uc, E.Y., Bonnard, A., Sornette, D. & Broussolle, E. (2013) Impact of specific executive functions on driving performance in people with Parkinson's disease. Movement Disord., 28, 1941-1948.
28. Robbins, T.W. & Cools, R. (2014) Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective. Movement Disord., 29, 597-607.
29. Schrag, A., Barone, P., Brown, R.G., Leentjens, A.F., McDonald, W.M., Starkstein, S., Weintraub, D., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G.T. & Goetz, C.G. (2007) Depression rating scales in Parkinson's disease: critique and recommendations. Movement Disord., 22, 1077-1092.
30. Singleton, A.B., Farrer, M.J. & Bonifati, V. (2012) The genetics of Parkinson's disease: Progress and therapeutic implications. Movement Disord., 28, 14-23.
31. Somme, J.H., Molano Salazar, A., Gonzalez, A., Tijero, B., Berganzo, K., Lezcano, E., Fernandez Martinez, M., Zarranz, J.J. & Gómez-Esteban, J.C. (2015) Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene. Parkinsonism Relat. D., 21, 494-499.
32. Thaler, A., Ash, E., Gan-Or, Z., Orr-Urtreger, A. & Giladi, N. (2009) The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews. J. Neural. Transm., 116, 1473-1482.
33. Thaler, A., Mirelman, A., Gurevich, T., Simon, E., Orr-Urtreger, A., Marder, K., Bressman, S., Giladi, N. & LRRK2 Ashkenazi Jewish Consortium. (2012) Lower cognitive performance in healthy G2019S LRRK2 mutation carriers. Neurology, 79, 1027-1032.
34. Thaler, A., Mirelman, A., Helmich, R.C., van Nuenen, B.F., Rosenberg-Katz, K., Gurevich, T., Orr-Urtreger, A., Marder, K., Bressman, S., Bloem, B.R., Giladi, N., Hendler, T. & LRRK2 Ashkenazi Jewish consortium (2013) Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers. Cortex, 49, 2501-2511.
35. Trujillo, J.P., Gerrits, N.J., Veltman, D.J., Berendse, H.W., van der Werf, Y.D. & van den Heuvel, O.A. (2015) Reduced neural connectivity but increased task-related activity during working memory in de novo Parkinson patients. Hum. Brain Mapp., 36, 1554-1566.
36. Weintraub, D., Simuni, T., Caspell-Garcia, C., Coffey, C., Lasch, S., Siderowf, A., Aarsland, D., Barone, P., Burn, D., Chahine, L.M., Eberling, J., Espay, A.J., Foster, E.D., Leverenz, J.B., Litvan, I., Richard, I., Troyer, M.D., Hawkins, K.A. & Parkinson's Progression Markers Initiative. (2015) Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Movement Disord., 30, 919-927.
37. Weschler, D. (1991) Weschler Adult Intelligence Scale-III. The Psychological Corporation, New-York.
38. Zabetian, C.P., Hutter, C.M., Yearout, D., Lopez, A.N., Factor, S.A., Griffith, A., Leis, B.C., Bird, T.D., Nutt, J.G., Higgins, D.S., Roberts, J.W., Kay, D.M., Edwards, K.L., Samii, A. & Payami, H. (2006) LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am. J. Hum. Genet., 79, 752-758.